- Home
- DSGR vs NEO Comparison
DSGR vs NEO Comparison
Compare DSGR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSGR | NEO |
|---|---|---|
| Founded | 1952 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | DSGR | NEO |
|---|---|---|
| Price | $29.00 | $11.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $41.00 | $12.56 |
| AVG Volume (30 Days) | 72.1K | ★ 1.8M |
| Earning Date | 10-30-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,978,887,000.00 | $709,162,000.00 |
| Revenue This Year | $12.80 | $10.90 |
| Revenue Next Year | $4.23 | $9.88 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.46 | 10.10 |
| 52 Week Low | $21.87 | $4.72 |
| 52 Week High | $39.45 | $19.12 |
Technical Indicators
Market Signals| Indicator | DSGR | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 62.08 | 60.77 |
| Support Level | $26.98 | $11.59 |
| Resistance Level | $28.05 | $12.26 |
| Average True Range (ATR) | 1.10 | 0.42 |
| MACD | 0.26 | -0.07 |
| Stochastic Oscillator | 92.68 | 49.80 |
Price Performance
Historical ComparisonAbout DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.